BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19739038)

  • 1. Hormones and cardiovascular disease: a shift in paradigm with clinical consequences?
    van Zaane B; Reuwer AQ; Büller HR; Kastelein JJ; Gerdes VE; Twickler MT
    Semin Thromb Hemost; 2009 Jul; 35(5):478-87. PubMed ID: 19739038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid diseases, dyslipidemia and cardiovascular pathology.
    Neves C; Alves M; Medina JL; Delgado JL
    Rev Port Cardiol; 2008 Oct; 27(10):1211-36. PubMed ID: 19178025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How corticoids, growth hormone and oestrogens influence lipids and atherosclerosis].
    Marek J; Hána V; Krsek M
    Vnitr Lek; 2007 Apr; 53(4):386-90. PubMed ID: 17578171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic changes in persons after spinal cord injury.
    Bauman WA; Spungen AM
    Phys Med Rehabil Clin N Am; 2000 Feb; 11(1):109-40. PubMed ID: 10680161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation.
    Ferri N; Paoletti R; Corsini A
    Curr Opin Lipidol; 2006 Oct; 17(5):495-501. PubMed ID: 16960497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers.
    Toh SA; Rader DJ
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1007-22. PubMed ID: 18666851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hormones in the regulation of lipoprotein metabolism (review).
    Hromadová M
    Endocrinol Exp; 1985 Dec; 19(4):318-30. PubMed ID: 3910409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
    Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
    Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormones in the critically ill patient: to intervene or not to intervene?
    Ligtenberg JJ; Girbes AR; Beentjes JA; Tulleken JE; van der Werf TS; Zijlstra JG
    Intensive Care Med; 2001 Oct; 27(10):1567-77. PubMed ID: 11685296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subclinical hypothyroidism: a cardiovascular risk factor?].
    Cohen-Aubart F; Jublanc C; Chiche F; Bruckert E
    Arch Mal Coeur Vaiss; 2007 Mar; 100(3):213-6. PubMed ID: 17536425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones in wellness and disease prevention: common practices, current state of the evidence, and questions for the future.
    Schwartz ET; Holtorf K
    Prim Care; 2008 Dec; 35(4):669-705. PubMed ID: 18928825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid disease and the heart.
    Klein I; Danzi S
    Circulation; 2007 Oct; 116(15):1725-35. PubMed ID: 17923583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of the hormonal metabolic regulations in ischemic heart disease with respect to primary prophylaxis].
    Marek H
    Z Gesamte Inn Med; 1980 May; 35(10):389-92. PubMed ID: 7001776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormones in bone metabolism. II. Other systemic hormones].
    Zák J; Broulík P; Sonka J; Marek J
    Cas Lek Cesk; 1990 Dec; 129(50):1578-81. PubMed ID: 2272074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothyroidism and cerebral infarction: a case report and literature review.
    Sun MY; Chen TC; Lee YL
    Acta Neurol Taiwan; 2006 Sep; 15(3):197-200. PubMed ID: 16995600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up.
    Buemi M; Bolignano D; Barilla A; Nostro L; Crasci E; Campo S; Coppolino G; D'Anna R
    J Nephrol; 2008; 21(5):663-72. PubMed ID: 18949720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infective agents and cardiovascular disease.
    Nieto FJ
    Semin Vasc Med; 2002 Nov; 2(4):401-15. PubMed ID: 16222630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-counteracting hormones: their impact on glucose metabolism.
    Bratusch-Marrain PR
    Diabetologia; 1983 Feb; 24(2):74-9. PubMed ID: 6341138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal control of growth].
    Rappaport R
    Arch Fr Pediatr; 1982; 39(6):387-97. PubMed ID: 6751266
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular changes in thyroid disorder.
    Gupta R; Varma Y; Yadav BS; Gupta R; Gupta S; Gupta N
    J Indian Med Assoc; 2006 Oct; 104(10):574, 576-8. PubMed ID: 17380822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.